D-208-2013 Class III Terminated
FDA drug recall D-208-2013 was initiated by Novartis Consumer Health on Mar 7, 2013 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible. The recall status is terminated (terminated Nov 26, 2014). Affected quantity: 91,872/1-oz. tubes and 94,464/2-oz. tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 27, 2013
- Initiation Date
- Mar 7, 2013
- Termination Date
- Nov 26, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 91,872/1-oz. tubes and 94,464/2-oz. tubes
Product description
Nupercainal, Dibucaine, Hemorrhoidal & Topical Analgesic Ointment, a) 1-oz. tubes (NDC 0067-5812-96), b) 2-oz. tubes (NDC 0067-5812-86), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.
Distribution pattern
Nationwide and Panama
Code information
Lot #: a) 10109149, 10111499, 10117160, 10119603, and 10121763, Exp 4/13 to 8/13; b) 10109148, 10112258, 10113806, 10115615, 10117161, 10119604, 10119605, 10121782, and 10122762, Exp 3/13 to 9/13.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-208-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026